These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 1506478)

  • 1. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1990 Jan; 291(4):553-82. PubMed ID: 2329191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lesion of the developing central noradrenergic system: short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts.
    Coradazzi M; Gulino R; Garozzo S; Leanza G
    J Neurochem; 2010 Aug; 114(3):761-71. PubMed ID: 20477936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimentally-induced neuron loss in the locus coeruleus of adult rats.
    Fritschy JM; Grzanna R
    Exp Neurol; 1991 Jan; 111(1):123-7. PubMed ID: 1984427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal 6-hydroxydopamine destroys spinal cord noradrenergic axons from the locus coeruleus, but not those from lateral tegmental cell groups.
    McBride RL; Ozment RV; Sutin J
    J Comp Neurol; 1985 May; 235(3):375-83. PubMed ID: 3923062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
    Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
    Zhang X; Zuo DM; Yu PH
    Neurosci Lett; 1995 Feb; 186(1):45-8. PubMed ID: 7540268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy.
    Giorgi FS; Mauceli G; Blandini F; Ruggieri S; Paparelli A; Murri L; Fornai F
    Epilepsia; 2006; 47 Suppl 5():21-5. PubMed ID: 17239101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of locus coeruleus axons within the rat brainstem demonstrated by Phaseolus vulgaris leucoagglutinin anterograde tracing in combination with dopamine-beta-hydroxylase immunofluorescence.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1990 Mar; 293(4):616-31. PubMed ID: 2329197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.
    Horvath TL; Peyron C; Diano S; Ivanov A; Aston-Jones G; Kilduff TS; van Den Pol AN
    J Comp Neurol; 1999 Dec; 415(2):145-59. PubMed ID: 10545156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report.
    Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
    Neurosci Lett; 2010 Sep; 481(2):102-4. PubMed ID: 20599586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
    Radwanska K; Nikolaev E; Kaczmarek L
    Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Lacroix D; Blier P; Curet O; de Montigny C
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerating and sprouting axons differ in their requirements for growth after injury.
    Bernstein-Goral H; Diener PS; Bregman BS
    Exp Neurol; 1997 Nov; 148(1):51-72. PubMed ID: 9398450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.